These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 12168870)

  • 1. DNA-dependent protein kinase in leukaemia cells and correlation with drug sensitivity.
    Eriksson A; Lewensoh R; Larsson R; Nilsson A
    Anticancer Res; 2002; 22(3):1787-93. PubMed ID: 12168870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of DNA-dependent protein kinase activity in leukemic cells.
    Muller C; Salles B
    Oncogene; 1997 Nov; 15(19):2343-8. PubMed ID: 9393878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of chlorambucil cytotoxicity in B-cell chronic lymphocytic leukemia by inhibition of DNA-dependent protein kinase activity using wortmannin.
    Christodoulopoulos G; Muller C; Salles B; Kazmi R; Panasci L
    Cancer Res; 1998 May; 58(9):1789-92. PubMed ID: 9581813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA-dependent protein kinase is a therapeutic target and an indicator of poor prognosis in B-cell chronic lymphocytic leukemia.
    Willmore E; Elliott SL; Mainou-Fowler T; Summerfield GP; Jackson GH; O'Neill F; Lowe C; Carter A; Harris R; Pettitt AR; Cano-Soumillac C; Griffin RJ; Cowell IG; Austin CA; Durkacz BW
    Clin Cancer Res; 2008 Jun; 14(12):3984-92. PubMed ID: 18559621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etoposide-induced DNA strand breaks in relation to p-glycoprotein and topoisomerase II protein expression in leukaemic cells from patients with AML and CLL.
    Zhou R; Vitols S; Gruber A; Liliemark J; Wang Y; Liliemark E
    Br J Haematol; 1999 May; 105(2):420-7. PubMed ID: 10233413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of DNA-PKcs and Ku86, but not Ku70, differs between lymphoid malignancies.
    Holgersson A; Erdal H; Nilsson A; Lewensohn R; Kanter L
    Exp Mol Pathol; 2004 Aug; 77(1):1-6. PubMed ID: 15215044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitoxantrone in combination with an inhibitor of DNA-dependent protein kinase: a potential therapy for high risk B-cell chronic lymphocytic leukaemia.
    Elliott SL; Crawford C; Mulligan E; Summerfield G; Newton P; Wallis J; Mainou-Fowler T; Evans P; Bedwell C; Durkacz BW; Willmore E
    Br J Haematol; 2011 Jan; 152(1):61-71. PubMed ID: 21083655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug resistance mechanisms in chronic lymphocytic leukemia.
    Ribrag V; Massade L; Faussat AM; Dreyfus F; Bayle C; Gouyette A; Marie JP
    Leukemia; 1996 Dec; 10(12):1944-9. PubMed ID: 8946935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alkylator resistance in human B lymphoid cell lines: (2). Increased levels of topoisomerase II expression and function in a melphalan-resistant B-CLL cell line.
    Pu QQ; Bezwoda WR
    Anticancer Res; 2000; 20(4):2569-78. PubMed ID: 10953328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA-PK, ATM and MDR proteins inhibitors in overcoming fludarabine resistance in CLL cells.
    Svirnovski AI; Serhiyenka TF; Kustanovich AM; Khlebko PV; Fedosenko VV; Taras IB; Bakun AV
    Exp Oncol; 2010 Dec; 32(4):258-62. PubMed ID: 21270755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA-dependent protein kinase is inhibited by trifluoperazine.
    Eriksson A; Yachnin J; Lewensohn R; Nilsson A
    Biochem Biophys Res Commun; 2001 May; 283(4):726-31. PubMed ID: 11350043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA-Dependent protein kinase activity correlates with clinical and in vitro sensitivity of chronic lymphocytic leukemia lymphocytes to nitrogen mustards.
    Muller C; Christodoulopoulos G; Salles B; Panasci L
    Blood; 1998 Oct; 92(7):2213-9. PubMed ID: 9746757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The kinase activity of DNA-PK is required to protect mammalian telomeres.
    Bailey SM; Brenneman MA; Halbrook J; Nickoloff JA; Ullrich RL; Goodwin EH
    DNA Repair (Amst); 2004 Mar; 3(3):225-33. PubMed ID: 15177038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors affecting bryostatin 1-enhanced 2-CdA cytotoxicity in resistant B-cell chronic lymphocytic leukemia.
    Beck FW; Eilender DS; Dandashi MH; Siddiq F; Snell DC; Godmere MA; Al-Katib AM; Mohammad RM
    Int J Mol Med; 2004 Jul; 14(1):113-9. PubMed ID: 15202025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the DNA-PK binding protein E4-34K fails to confer radiation sensitivity to mammalian cells.
    Collis SJ; Ketner GW; Hicks JL; Nelson WG; Demarzo AM; Deweese TL
    Int J Radiat Biol; 2003 Jan; 79(1):53-60. PubMed ID: 12556331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allotype imbalance or microsatellite mutation in low-grade soft tissue sarcomas of the extremities in adults.
    Cho NH; Cordon-Cardo C; Li GC; Kim SH
    J Pathol; 2002 Sep; 198(1):21-9. PubMed ID: 12210059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of correlation between DNA-dependent protein kinase activity and tumor cell radiosensitivity.
    Allalunis-Turner MJ; Lintott LG; Barron GM; Day RS; Lees-Miller SP
    Cancer Res; 1995 Nov; 55(22):5200-2. PubMed ID: 7585574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactive oxygen species elicit apoptosis by concurrently disrupting topoisomerase II and DNA-dependent protein kinase.
    Lu HR; Zhu H; Huang M; Chen Y; Cai YJ; Miao ZH; Zhang JS; Ding J
    Mol Pharmacol; 2005 Oct; 68(4):983-94. PubMed ID: 16024664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and activity of DNA-dependent protein kinase in normal human leukocytes.
    Eriksson A; Lewensohn R; Nilsson A
    Anticancer Res; 2000; 20(5A):3051-8. PubMed ID: 11062722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical studies of immunohistochemical staining of DNA-dependent protein kinase in oropharyngeal and hypopharyngeal carcinomas.
    Sakata K; Matsumoto Y; Satoh M; Oouchi A; Nagakura H; Koito K; Hosoi Y; Hareyama M; Suzuki N
    Radiat Med; 2001; 19(2):93-7. PubMed ID: 11383649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.